X. Liang

Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis

Lin Zhu, Mei Lin, Li-Shan Peng, 2021, Digestive Diseases and Sciences.

Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross‐sectional survey

Jian Sun, Xieer Liang, J. Hou, 2017, Journal of viral hepatitis.

[Effects of Sidaxue, a Miao ethnomedicine recipe, on apoptosis and pyrolysis of human fibroblast-like synovial cells in rheumatoid arthritis].

J. Sun, M. Li, X. Liang, 2021, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Oxygen Reduction Reaction on sulfur doped graphene by density functional study: Oxygen Reduction Reaction on sulfur doped graphene by density functional study

X. Liang, J. Sun, 2016 .

Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C—can one size fit all?

J. Hou, R. Fan, X. Liang, 2018, Alimentary pharmacology & therapeutics.

Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B

S. Chen, Y. Wang, H. Liu, 2018, Journal of viral hepatitis.

Interpretation of liver stiffness measurement‐based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2‐year prospective study

S. Chen, Q. Ning, J. Niu, 2018, Journal of viral hepatitis.

[Prevalence and risk factors of nonalcoholic fatty liver disease in patients with chronic hepatitis B receiving antiviral therapy].

H. Gao, R. Fan, Z. Kuang, 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Commentary: prognostication of chronic hepatitis B ‐ are Fibrotest and Fibroscan the final answers?

V. Wong, X. Liang, J. Sun, 2013, Alimentary pharmacology & therapeutics.